Lonza submits non-binding proposal to acquire all Patheon Inc
The Special Committee of Independent Directors of Patheon Inc. and Lonza Group AG announced that Lonza, one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries, has submitted a non-binding proposal to acquire all of the outstanding Restricted Voting Shares of Patheon at a price of USD 3.55 per Restricted Voting Share.
Comments